Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 January 2025 | Story Martinette Brits | Photo Barend Nagel
MASSTER Project
The University of the Free State (UFS) recently welcomed distinguished international partners for the MASSTER project.

The University of the Free State (UFS) recently hosted a group of distinguished international partners as part of the MASSTER project (Managing (South) Africa and Senegal Sustainability Targets through Economic-diversification of Rural-areas). Funded by the European Union Erasmus programme (Project ID 101129023), the project aims to support the agricultural sector in Sub-Saharan Africa (SSA) and Senegal by addressing pressing issues such as rural migration, food security, and sustainable development. 

 

What is the MASSTER Project? 

Launched in early 2024, the MASSTER project is an ambitious initiative designed to enhance agricultural development and economic diversification in rural areas across SSA, with a particular focus on Senegal and South Africa. According to Prof Corli Witthuhn from the Department of Sustainable Food Systems and Development at UFS, who serves as the project’s coordinator, researcher and trainer, MASSTER  seeks to make a lasting impact on the sector. 

“Agriculture plays a vital role in these regions, contributing up to 40% of GDP and providing livelihoods for over 70% of the population. However, challenges such as rural-urban migration and underutilised agricultural potential hinder the growth of this crucial sector,” explains Prof Witthuhn. 

By offering innovative training and educational tools to farmers and agricultural students, the project aims to bridge these gaps.  It involves higher education institutions (HEIs) in community development and focuses on the intersection of agriculture and migration. In doing so, MASSTER contributes to key Sustainable Development Goals (SDGs), including zero hunger, quality education, decent work, and economic growth.


Key objectives of the MASSTER Project

MASSTER collaborates with six partner HEIs in Senegal and South Africa to tackle pressing agricultural and migration challenges. The project focuses on: 

  • Assisting local farmers in implementing income-generating activities.
  • Supporting extension services in delivering relevant training programmes that emphasise economic sustainability.
  • Helping municipalities manage economic migration, particularly from rural areas.

To achieve these objectives, MASSTER analyses the risk factors that drive migration and those that prevent it, designing training programmes that empower current and future farmers to generate income. It also provides Training of Trainers (TOT) to HEIs and extension services, equipping them with skills to deliver impactful training sessions. Additionally, the project helps HEIs develop comprehensive migration management strategies that foster a whole-of-society approach linking agriculture and migration policies. 


A global collaborative effort

The MASSTER project brings together a diverse consortium of partners from Senegal, South Africa and Europe, including: 

  • Senegal: Université Du Sine Saloum El-Hâdj Ibrahima Niass Kaolack (USSEIN), Université Gaston Berger Saint- Louis (UGB), Université Assane Seck de Ziguinchor (UASZ), Interprofessional Center for Training in Agriculture (CIFA)
  • South Africa: University of the Free State (UFS), Stellenbosch University (SU), Tshwane University of Technology (TUT), South African Society for Agricultural Extension (SASAE)
  • Germany: Hochschule Weihenstephan-Triesdorf (HSWT)
  • France: Universite D’Aix-Marseille (AMU)
  • Italy: University of Naples Federico II (UNINA)
  • Serbia: Academy of Professional Studies South Serbia and Western Balkans Institute

Benefits for the University of the Free State

The MASSTER project presents significant opportunities for the UFS. It enables researchers to collaborate with international partners on groundbreaking research that addresses urgent agricultural challenges. Prof Witthuhn highlights that the project also provides valuable third-stream funding for the UFS research initiatives, strengthening the university’s broader academic and community development efforts. 

Additionally, UFS researchers gain hands-on experience in European Union grant administration, potentially paving the way for future EU-funded projects. The project fosters direct engagement with local farming communities by offering training that empowers farmers and promotes rural development. Moreover, it enhances the university’s expertise in agricultural sustainability and migration management.


Partners’ visit to UFS

The recent visit by MASSTER project partners to the UFS marked a key milestone in this collaboration. During their stay, the group participated in various activities, including farm visits and discussions aimed at advancing the project’s objectives.

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept